Illinois man accused of insider trading after making nearly $100K on Pfizer-Array buyout

19 Oct 2023
AcquisitionPatent Infringement
A suburban Chicago man who used insider information he got from his spouse, who worked at Array BioPharma, to make nearly $100,000 from buying and selling stock options will now face charges in a federal court, according to government documents. The spouse and companies involved are unnamed by the US Attorney’s Office for the Northern District of Illinois, which put out a press release Wednesday, and in court records. But a release and complaint from the SEC specified the allegations: The “suburban Chicago man,” Brian Rubin, is facing accusations of buying stock options in Array before it was announced that it would be acquired by Pfizer for $11.4 billion in June 2019.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.